The shares were bought back between March 3 and March 10, 2025. This buyback was part of an ongoing program approved by the company’s board in August 2022, which allows for up to $40 million of stock to be repurchased. With these recent purchases, around 1.1 million shares have been retired.
Dan Burton, CEO of Health Catalyst, explained, “Repurchasing these shares shows our belief in the strength of our business. We feel that the current market doesn’t reflect the true long-term value of our stock. This move underscores our commitment to providing lasting value to our shareholders, clients, and team members.”
About Health Catalyst
Health Catalyst focuses on transforming healthcare via data. Their platform, Health Catalyst Ignite™, offers cloud-based technology and AI-driven solutions that enhance clinical, financial, and operational outcomes. Over 1,000 healthcare organizations worldwide depend on their services, aiming to turn complex data into meaningful insights. With years of experience and a history of delivering significant results, Health Catalyst remains dedicated to improving healthcare through data-informed strategies.
Important Note
This announcement includes forward-looking statements about Health Catalyst’s future growth and stock performance. These statements depend on assumptions that might not hold true. Many factors can affect the company’s actual performance, including regulatory changes and economic conditions. For more information on risks, please refer to Health Catalyst’s SEC reports, particularly their Annual Report on Form 10-K.
Contact Information
For investor inquiries, reach out to Jack Knight, Vice President of Investor Relations, at +1 (855)-309-6800 or ir@healthcatalyst.com. For media inquiries, contact Kathryn Mykleseth at media@healthcatalyst.com.
Check out this related article: Urgent Update: Ukraine Health Cluster’s Collaborative Emergency Response to Ongoing Attacks – February 28, 2025
Source linkHCAT, Health Catalyst, stock buyback, share repurchase program, healthcare technology, corporate strategy, investor confidence
